Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Strong

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 25, 2002
Biochemical markers: summaryMichael J Strong
Expert Opinion on Investigational Drugs|November 30, 2004
Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapyMichael J Strong
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 30, 2008
The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosisMichael J Strong
Journal of the Neurological Sciences|October 21, 2009
The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)Michael J Strong
Archives of Neurology|March 15, 2006
ALS--not what we thoughtMichael J Strong
Journal of Neurochemistry|December 2, 2022
SARS-CoV-2, aging, and Post-COVID-19 neurodegenerationMichael J Strong
Neurology|September 19, 2018
Author response: Pathologic ThrMichael J Strong
Current Opinion in Neurology|September 16, 2017
Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expressionMichael J Strong
Pharmacology & Therapeutics|June 5, 2003
The basic aspects of therapeutics in amyotrophic lateral sclerosisMichael J Strong
Free Radical Biology & Medicine|December 13, 2006
Loss of nitric oxide-mediated down-regulation of NMDA receptors in neurofilament aggregate-bearing motor neurons in vitro: implications for motor neuron diseaseTeresa Sanelli, Michael J Strong
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 25, 2002
Biochemical markers: summaryMichael J Strong
Expert Opinion on Investigational Drugs|November 30, 2004
Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapyMichael J Strong
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 30, 2008
The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosisMichael J Strong
Journal of the Neurological Sciences|October 21, 2009
The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)Michael J Strong
Archives of Neurology|March 15, 2006
ALS--not what we thoughtMichael J Strong
Journal of Neurochemistry|December 2, 2022
SARS-CoV-2, aging, and Post-COVID-19 neurodegenerationMichael J Strong
Neurology|September 19, 2018
Author response: Pathologic ThrMichael J Strong
Current Opinion in Neurology|September 16, 2017
Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expressionMichael J Strong
Pharmacology & Therapeutics|June 5, 2003
The basic aspects of therapeutics in amyotrophic lateral sclerosisMichael J Strong
Free Radical Biology & Medicine|December 13, 2006
Loss of nitric oxide-mediated down-regulation of NMDA receptors in neurofilament aggregate-bearing motor neurons in vitro: implications for motor neuron diseaseTeresa Sanelli, Michael J Strong
Pageof 22